Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-25 @ 12:37 AM
NCT ID:
NCT03331367
Eligibility Criteria:
Inclusion Criteria:
* Patient is willing and able to freely sign informed consent to enroll in the study.
* Histologically proven Prostate Carcinoma.
* Undergoing total cryotherapy, focal cryotherapy, Cyberknife SBRT or radical prostatectomy for prostate cancer treatment.
Exclusion Criteria:
* Has previously had a radical prostatectomy for prostate cancer.
* Has previously received cryotherapy for prostate cancer.
* Previous treatment with chemotherapy within the past 6 months.
* Previous treatment with radiation within the past 18 months.
* Has evidence of metastatic disease.
* Has a current or history within the past 6 months of alcohol and/or substance abuse which would impair participation in the study.
* Has a major medical disorder (i.e. uncontrolled diabetes, significant hepatic, renal or hematological disorders, recent stroke or myocardial infarction), in the opinion of the urologist, is an illness or complication which is not consistent with the protocol requirements.
* Is not willing to undergo the necessary follow-up for the trial period.
* Has known immunologic disease, human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT03331367
Study Brief:
Protocol Section:
NCT03331367